Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial

Guerrieri-Gonzaga, A., Serrano, D., Thomas, P., Crew, K. D., Kumar, N. B., Gandini, S., Vornik, L. A., Lee, J., Cagnacci, S., Vicini, E., Accornero, C. A., D’Amico, M., Guasone, F., Spinaci, S., Webber, T. B., Brown, P. H., Szabo, E., Heckman-Stoddard, B., & Bonanni, B. (2021). Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial. Contemporary Clinical Trials, 107, 106498. https://doi.org/10.1016/j.cct.2021.106498
Authors:
Aliana Guerrieri-Gonzaga
Davide Serrano
Parjhitham Thomas
Katherine D. Crew
Nagi B. Kumar
Sara Gandini
Lana A. Vornik
Jack Lee
Sara Cagnacci
Elisa Vicini
Chiara A. Accornero
Mauro D'Amico
Flavio Guasone
Stefano Spinaci
Tania B. Webber
Powel H. Brown
Eva Szabo
Brandy Heckman-Stoddard
Bernardo Bonanni
Affiliated Authors:
Katherine D. Crew
Author Keywords:
breast cancer
drug schedule and alternative dose
exemestane
phase ii study
preventive medicine
Publication Type:
Article
Unique ID:
10.1016/j.cct.2021.106498
PMID:
Publication Date:
Data Source:
Scopus

Record Created: